183 related articles for article (PubMed ID: 26520229)
1. Enzymatic diagnosis of Fabry disease using a fluorometric assay on dried blood spots: An alternative methodology.
Caudron E; Prognon P; Germain DP
Eur J Med Genet; 2015 Dec; 58(12):681-4. PubMed ID: 26520229
[TBL] [Abstract][Full Text] [Related]
2. [Fabry disease: enzymatic screening using dried blood spots on filter paper].
Caudron E; Germain DP; Prognon P
Rev Med Interne; 2010 Dec; 31 Suppl 2():S263-9. PubMed ID: 21211677
[TBL] [Abstract][Full Text] [Related]
3. Diagnosing lysosomal storage disorders: Fabry disease.
Bodamer OA; Johnson B; Dajnoki A
Curr Protoc Hum Genet; 2013; Chapter 17():Unit17.13. PubMed ID: 23595598
[TBL] [Abstract][Full Text] [Related]
4. Immunoquantification of alpha-galactosidase: evaluation for the diagnosis of Fabry disease.
Fuller M; Lovejoy M; Brooks DA; Harkin ML; Hopwood JJ; Meikle PJ
Clin Chem; 2004 Nov; 50(11):1979-85. PubMed ID: 15364892
[TBL] [Abstract][Full Text] [Related]
5. Effect of sample collection on alpha-galactosidase A enzyme activity measurements in dried blood spots on filter paper.
Olivova P; van der Veen K; Cullen E; Rose M; Zhang XK; Sims KB; Keutzer J; Browning MF
Clin Chim Acta; 2009 May; 403(1-2):159-62. PubMed ID: 19245803
[TBL] [Abstract][Full Text] [Related]
6. Newborn screening for Fabry disease by measuring GLA activity using tandem mass spectrometry.
Dajnoki A; Fekete G; Keutzer J; Orsini JJ; De Jesus VR; Chien YH; Hwu WL; Lukacs Z; Mühl A; Zhang XK; Bodamer O
Clin Chim Acta; 2010 Oct; 411(19-20):1428-31. PubMed ID: 20338160
[TBL] [Abstract][Full Text] [Related]
7. Whole-blood alpha-D-galactosidase A activity for the identification of Fabry's patients.
Massaccesi L; Burlina A; Baquero CJ; Goi G; Burlina AP; Tettamanti G
Clin Biochem; 2011 Jul; 44(10-11):916-21. PubMed ID: 21515249
[TBL] [Abstract][Full Text] [Related]
8. Multiplex newborn screening for Pompe, Fabry, Hunter, Gaucher, and Hurler diseases using a digital microfluidic platform.
Sista RS; Wang T; Wu N; Graham C; Eckhardt A; Winger T; Srinivasan V; Bali D; Millington DS; Pamula VK
Clin Chim Acta; 2013 Sep; 424():12-8. PubMed ID: 23660237
[TBL] [Abstract][Full Text] [Related]
9. A tandem mass spectrometry triplex assay for the detection of Fabry, Pompe, and mucopolysaccharidosis-I (Hurler).
Duffey TA; Bellamy G; Elliott S; Fox AC; Glass M; Turecek F; Gelb MH; Scott CR
Clin Chem; 2010 Dec; 56(12):1854-61. PubMed ID: 20940330
[TBL] [Abstract][Full Text] [Related]
10. Ultramicro-fluorometric assay for the diagnosis of Gaucher disease in dried blood spots on filter paper.
Herrera D; Monaga M; Campos D; Pampín Y; González EC; Lavaut K
J Neonatal Perinatal Med; 2013; 6(1):61-7. PubMed ID: 24246460
[TBL] [Abstract][Full Text] [Related]
11. Comparing the alpha-galactosidase A biochemical properties from healthy individuals and Fabry disease patients.
Daitx VV; Mezzalira J; Moraes Vda C; Breier AC; Cé J; Coelho JC
Clin Chim Acta; 2015 May; 445():60-4. PubMed ID: 25804996
[TBL] [Abstract][Full Text] [Related]
12. Correlation of Lyso-Gb3 levels in dried blood spots and sera from patients with classic and Later-Onset Fabry disease.
Nowak A; Mechtler T; Kasper DC; Desnick RJ
Mol Genet Metab; 2017 Aug; 121(4):320-324. PubMed ID: 28663131
[TBL] [Abstract][Full Text] [Related]
13. Detection of α-Galactosidase A Reaction in Samples Extracted from Dried Blood Spots Using Ion-Sensitive Field Effect Transistors.
Kuznetsov A; Sheshil A; Smolin E; Grudtsov V; Ryazantsev D; Shustinskiy M; Tikhonova T; Kitiashvili I; Vechorko V; Komarova N
Sensors (Basel); 2024 Jun; 24(11):. PubMed ID: 38894470
[TBL] [Abstract][Full Text] [Related]
14. Newborn screening for Fabry disease in the north-west of Spain.
Colon C; Ortolano S; Melcon-Crespo C; Alvarez JV; Lopez-Suarez OE; Couce ML; Fernández-Lorenzo JR
Eur J Pediatr; 2017 Aug; 176(8):1075-1081. PubMed ID: 28646478
[TBL] [Abstract][Full Text] [Related]
15. Pilot study of newborn screening for six lysosomal storage diseases using Tandem Mass Spectrometry.
Elliott S; Buroker N; Cournoyer JJ; Potier AM; Trometer JD; Elbin C; Schermer MJ; Kantola J; Boyce A; Turecek F; Gelb MH; Scott CR
Mol Genet Metab; 2016 Aug; 118(4):304-9. PubMed ID: 27238910
[TBL] [Abstract][Full Text] [Related]
16. Direct comparison of enzyme measurements from dried blood and leukocytes from male and female Fabry disease patients.
Lukacs Z; Hartung R; Beck M; Keil A; Mengel E
J Inherit Metab Dis; 2007 Aug; 30(4):614. PubMed ID: 17694354
[TBL] [Abstract][Full Text] [Related]
17. Newborn Screening for Fabry Disease in Northeastern Italy: Results of Five Years of Experience.
Gragnaniello V; Burlina AP; Polo G; Giuliani A; Salviati L; Duro G; Cazzorla C; Rubert L; Maines E; Germain DP; Burlina AB
Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34199132
[TBL] [Abstract][Full Text] [Related]
18. Digital microfluidic platform for multiplexing enzyme assays: implications for lysosomal storage disease screening in newborns.
Sista RS; Eckhardt AE; Wang T; Graham C; Rouse JL; Norton SM; Srinivasan V; Pollack MG; Tolun AA; Bali D; Millington DS; Pamula VK
Clin Chem; 2011 Oct; 57(10):1444-51. PubMed ID: 21859904
[TBL] [Abstract][Full Text] [Related]
19. Fabry disease: a new approach for the screening of females in high-risk groups.
Pasqualim G; Simon L; Sperb-Ludwig F; Burin MG; Michelin-Tirelli K; Giugliani R; Matte U
Clin Biochem; 2014 May; 47(7-8):657-62. PubMed ID: 24582695
[TBL] [Abstract][Full Text] [Related]
20. Screening for Fabry disease using whole blood spots fails to identify one-third of female carriers.
Linthorst GE; Vedder AC; Aerts JM; Hollak CE
Clin Chim Acta; 2005 Mar; 353(1-2):201-3. PubMed ID: 15698608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]